2021 ICD-10-CM Code R89.0
Abnormal level of enzymes in specimens from other organs, systems and tissues
Valid for Submission
R89.0 is a billable diagnosis code used to specify a medical diagnosis of abnormal level of enzymes in specimens from other organs, systems and tissues. The code R89.0 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
The ICD-10-CM code R89.0 might also be used to specify conditions or terms like aspartate transaminase level, aspartate transaminase level, ast/sgot level abnormal, cardiac enzyme levels - finding, cardiac enzymes abnormal , cardiac enzymes abnormal - first set, etc.
According to ICD-10-CM guidelines this code should not to be used as a principal diagnosis code when a related definitive diagnosis has been established.
| ICD-10: | R89.0 |
| Short Description: | Abnormal level of enzymes in specimens from oth org/tiss |
| Long Description: | Abnormal level of enzymes in specimens from other organs, systems and tissues |
Code Classification
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code R89.0 are found in the index:
- - Abnormal, abnormality, abnormalities - See Also: Anomaly;
- - specimen
- - specified organ, system and tissue NOS - R89.9
- - enzyme level - R89.0
- - specified organ, system and tissue NOS - R89.9
- - specimen
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Aspartate transaminase level
- Aspartate transaminase level
- AST/SGOT level abnormal
- Cardiac enzyme levels - finding
- Cardiac enzymes abnormal
- Cardiac enzymes abnormal - first set
- Drug induction of cytochrome p450 CYP1A2 enzyme
- Drug induction of cytochrome p450 CYP2C19 enzyme
- Drug induction of cytochrome p450 CYP2C9 enzyme
- Drug induction of cytochrome p450 CYP3A enzyme
- Drug inhibition of cytochrome p450 CYP1A2 enzyme
- Drug inhibition of cytochrome p450 CYP2C19 enzyme
- Drug inhibition of cytochrome p450 CYP2C9 enzyme
- Drug inhibition of cytochrome p450 CYP2D6 enzyme
- Drug inhibition of cytochrome p450 CYP3A enzyme
- Increased aspartate transaminase level
- Increased cholesterol esters
- Increased immunoreactive trypsinogen level
- Raised cardiac enzyme or marker
- Substance induction of cytochrome p450 CYP1A2 enzyme
- Substance induction of cytochrome p450 CYP2E1 enzyme
- Substance induction of cytochrome p450 CYP3A enzyme
- Substance induction of cytochrome p450 enzyme
- Substance inhibition of cytochrome p450 CYP3A enzyme
- Substance inhibition of cytochrome p450 enzyme
Diagnostic Related Groups - MS-DRG Mapping
The ICD-10 code R89.0 is grouped in the following groups for version MS-DRG V38.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2020 through 09/30/2021.
Convert R89.0 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code R89.0 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
- 792.9 - Abn find-body subst NEC (Approximate Flag)
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)